Aurobindo Pharma Share Price

Aurobindo Pharma

CMP as on 27-Oct-21 15:51

₹ 706.60
3.10 0.44%

Open

₹ 704.70

Turnover (lac)

₹ 11,570

Prev. Close

₹ 703.50

Day's Vol (shares)

₹ 16,37,432

Day's Range (₹)

₹ 702.55
₹ 714.75

CMP as on27-Oct-21 15:53

₹ 706.10
2.3 0.33%

Open

₹ 701.00

Turnover (lac)

₹ 766

Prev. Close

₹ 703.80

Day's Vol (shares)

₹ 1,07,404

Day's Range

₹ 701.00
₹ 714.40

CMP as on 27-Oct-21 15:29

₹ 704.70
1.05 0.15%

Open

₹ 704.00

Open Interest(Contracts)

₹ 79,68,350

VWAP

₹ 709.72

Day's Vol (shares)

₹ 51,14,200

Day's Range (Ex.Dt. 28 Oct 2021)

₹ 703.60
₹ 716.25

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
AGM 26-Aug-2021 03-Aug-2021 - -
AGM 26/08/2021 Pursuant to Section 91 of the Companies Act, 2013 and Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Register of Members and Share Transfer Books will remain closed from Tuesday, August 24, 2021 to Thursday, August 26, 2021 (both days inclusive). Further to our letter dated August 3, 2021 intimating the date of 34th Annual General Meeting (AGM) of the Members of the Company and pursuant to Regulation 34 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015, please find enclosed Annual Report for the financial year 2020-21 along with Notice of 34th AGM of the Company to be held on Thursday, August 26, 2021 at 3.30 p.m. IST through Video Conferencing (VC) / Other Audio Visual Means (OAVM) which is being sent to the shareholders of the Company through electronic mode. The Annual Report containing the Notice is also being uploaded on the Companys website https://www.aurobindo.com/investors/results-reports-presentations/annual-reports/. (As Per BSE Announcement dated on 04.08.2021) In continuation to our letter dated August 4 2021 the 34th Annual General Meeting (AGM) of the Company was held on August 26 2021 and the business mentioned in the AGM Notice dated May 31 2021 was transacted. In this regard please find enclosed the following: 1. Summary of proceedings as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as Annexure- I. 2. Voting Results as required under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as Annexure- II. 3. The Report of Scrutinizer on remote evoting and voting at AGM (by electronic means) as Annexure- III. Aurobindo Pharma Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement Dated on 8/27/2021 4:03:48 AM)
Open ZERO Brokerage Demat Account